Kappa antagonist to prevent drug relapse: does stage in addiction cycle matter?

Ridzwan, Irna Elina and Zulkifli, Muhammad Harith and Wasli, Nur Syafinaz and Syd Mohmad Faudzi, Syed Mohd Syahmi (2016) Kappa antagonist to prevent drug relapse: does stage in addiction cycle matter? International Medical Journal Malaysia, 15 (Supplement issue). p. 67. ISSN 1823-4631

	PDF (Abstract - author's copy) - Submitted Version Restricted to Repository staff only Download (540kB) | Request a copy
Preview	PDF (abstract - published copy) - Published Version Download (328kB) | Preview

Abstract

Introduction: An upregulation of the kappa opioid receptor (KOR) system during preoccupation stage in addiction cycle will cause dysphoria among addicts which can lead to relapse. Therefore, KOR antagonism might hold the key to prevent relapse. In this study, we aim to identify the exact addiction's stage in which KOR antagonist can be given. Methods: Using a conditioned place preference (CPP) model, adult Swiss albino mice were divided into two major groups. The first group received treatment at the initial stage of morphine withdrawal (7.5 mg/kg. i.p) while the second group received treatment after complete abstinence was achieved. Each major groups were further divided into two treatment groups (n=8-12), either received a functional KOR antagonist (0.3 mg/kg buprenorphine/ 1mg/kg naltrexone combination, i.p) or a selective KOR antagonist (10 mg/kg nor-BNI, i.p) prior to morphine priming (2.5 mg/kg, i.p). All data were analyzed using paired sample t-test. Results: The results showed that relapse was successfully attenuated in the groups that received KOR antagonists only after complete abstinence was successfully achieved (not significantly different from their baseline). However, the mice developed unusual sign of behavior sensitization (intermittent freezing, licking) when buprenorphine/naltrexone combination was given at initial stage of withdrawal. Conclusion: Our initial findings suggest that KOR antagonism might be beneficial only after the addicts achieved complete abstinence to prevent future drug-induced relapse. Brain study should be conducted to explain the unusual behavior seen when the drug intervention is given at an earlier stage of withdrawal.

Item Type:	Article (Journal)
Additional Information:	5628/51525
Uncontrolled Keywords:	drug relapse, kappa antagonist, morphine
Subjects:	R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Kulliyyahs/Centres/Divisions/Institutes (Can select more than one option. Press CONTROL button):	Kulliyyah of Pharmacy > Department of Pharmaceutical Chemistry
Depositing User:	Dr Irna Elina Ridzwan
Date Deposited:	12 Aug 2016 10:56
Last Modified:	02 Jul 2018 15:39
URI:	http://irep.iium.edu.my/id/eprint/51525

Actions (login required)

View Item